Cargando…

In vitro co-metabolism of epigallocatechin-3-gallate (EGCG) by the mucin-degrading bacterium Akkermansia muciniphila

Akkermansia muciniphila is a Gram-negative bacterium that resides within the gut mucus layer, and plays an important role in promoting gut barrier integrity, modulating the immune response and inhibiting gut inflammation. Growth stimulation of A. muciniphila by polyphenols including epigallocatechin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yun, Zhang, Xuxiang, Jiang, Mingxin, Zhang, Hongbo, Wang, Yinfeng, Zhang, Yuyu, Seviour, Robert, Kong, Yunhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638859/ https://www.ncbi.nlm.nih.gov/pubmed/34855864 http://dx.doi.org/10.1371/journal.pone.0260757

Ejemplares similares

Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium
por: Si, Jiyeon, et al.
Publicado: (2022)

Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development
por: Kim, Seungil, et al.
Publicado: (2021)

Antibacterial Activity of Epigallocatechin Gallate (EGCG) against Shigella flexneri
por: Zhang, Yini, et al.
Publicado: (2023)

Elucidation of Akkermansia muciniphila Probiotic Traits Driven by Mucin Depletion
por: Shin, Jongoh, et al.
Publicado: (2019)

Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
por: Zhang, Qiang, et al.
Publicado: (2023)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila
por: Derrien, Muriel, et al.
Publicado: (2011)

Characterization of a phospholipid‐regulated β‐galactosidase from Akkermansia muciniphila involved in mucin degradation
por: Kosciow, Konrad, et al.
Publicado: (2019)

The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes
por: van Passel, Mark W. J., et al.
Publicado: (2011)

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
por: Zhong, Ying, et al.
Publicado: (2012)

Mechanism of (−)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma
por: Park, Seungil, et al.
Publicado: (2022)

Akkermansia muciniphila is a promising probiotic
por: Zhang, Ting, et al.
Publicado: (2019)

Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
por: Zhang, Xin, et al.
Publicado: (2016)

Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
por: Siblini, Hiba, et al.
Publicado: (2023)

Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea
por: Du, Guang-Jian, et al.
Publicado: (2012)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5′-O-α-Glucopyranoside, a Novel EGCG Derivative
por: Han, Sang Yun, et al.
Publicado: (2018)

Protective Effects of Epigallocatechin-3-gallate (EGCG) against the Jellyfish Nemopilema nomurai Envenoming
por: Li, Jie, et al.
Publicado: (2023)

The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis
por: Earley, Helen, et al.
Publicado: (2019)

Transcriptomics and metabolomics reveal the adaption of Akkermansia muciniphila to high mucin by regulating energy homeostasis
por: Liu, Xinyue, et al.
Publicado: (2021)

Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
por: Lei, Wenhui, et al.
Publicado: (2023)

Intelectin-1 binds and alters the localization of the mucus barrier–modifying bacterium Akkermansia muciniphila
por: Matute, Juan D., et al.
Publicado: (2022)

Monoalkylated Epigallocatechin-3-gallate (C18-EGCG) as Novel Lipophilic EGCG Derivative: Characterization and Antioxidant Evaluation
por: Minnelli, Cristina, et al.
Publicado: (2020)

Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
por: Mereles, Derliz, et al.
Publicado: (2011)

Anti-Fatigue Effect of Green Tea Polyphenols (-)-Epigallocatechin-3-Gallate (EGCG)
por: Teng, Yu-song, et al.
Publicado: (2017)

Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG)
por: Lorenz, Mario, et al.
Publicado: (2017)

Green Tea Catechin (-)-Epigallocatechin-3-Gallate (EGCG) Facilitates Fracture Healing
por: Lin, Sung-Yen, et al.
Publicado: (2020)

Effects of green tea extract epigallocatechin-3-gallate (EGCG) on oral disease-associated microbes: a review
por: Kong, Chen, et al.
Publicado: (2022)

Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer
por: Gu, Zhen-Yang, et al.
Publicado: (2021)

In Vitro Evaluation of the Antiviral Activity of the Synthetic Epigallocatechin Gallate Analog-Epigallocatechin Gallate (EGCG) Palmitate against Porcine Reproductive and Respiratory Syndrome Virus
por: Zhao, Chunjian, et al.
Publicado: (2014)

Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer
por: Zhang, Lingyu, et al.
Publicado: (2020)

The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation
por: Ouyang, Jing, et al.
Publicado: (2020)

Identification of a Novel Cobamide Remodeling Enzyme in the Beneficial Human Gut Bacterium Akkermansia muciniphila
por: Mok, Kenny C., et al.
Publicado: (2020)

Toxicological safety evaluation of pasteurized Akkermansia muciniphila
por: Druart, Céline, et al.
Publicado: (2020)

The evolution and competitive strategies of Akkermansia muciniphila in gut
por: Kim, Ji-Sun, et al.
Publicado: (2022)

Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
por: Hazgui, Salma, et al.
Publicado: (2008)

Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells
por: Park, Sunghoon, et al.
Publicado: (2014)

Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)
por: Chen, Hanyong, et al.
Publicado: (2015)

Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer
por: Negri, Aide, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tnlomubulvk39r3ihenrg968cd